Menu Search
Equities

Lifco AB (publ)

  • Add to watchlist
  • Add to portfolio
  • Add an alert
1L30:MUN

Lifco AB (publ)

Actions
  • Price (EUR)29.52
  • Today's Change-0.24 / -0.81%
  • Shares traded--
  • 1 Year change-8.72%
  • Beta1.3484
Data delayed at least 15 minutes, as of Feb 06 2026 07:00 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Lifco AB (publ), formerly Lifco AB, is a Sweden-based conglomerate of small and medium-sized companies. The Company offers a safe haven for small and medium-sized businesses. Business concept is to acquire and develop sustainable, niche businesses with the potential to deliver sustainable earnings growth and robust cash flows. Lifco AB (publ) operates in three segments: Dental, Demolition & Tools and Systems Solutions. Systems Solutions consists of a merger of those business areas which have similar economic characteristics and which do not individually meet the defined quantitative limits. The Company is involved in the distribution of dental equipment, such as denture attachments, disinfectants, saliva ejectors, bite registration and dental impression materials, bonding agents, and other consumables, as well as develops and sells medical record systems.

  • Revenue in SEK (TTM)28.25bn
  • Net income in SEK3.63bn
  • Incorporated1993
  • Employees7.81k
  • Location
    Lifco AB (publ)Verkmastaregatan 1ENKOPING 745 85SwedenSWE
  • Phone+46 171478450
  • Websitehttps://lifco.se/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status		LIFCO B:STO since
announced		Transaction
value
Ethoss Regeneration LtdDeal completed30 Jan 202630 Jan 2026Deal completed3.89%--
Karl Kaps GmbH Co. KGAnnounced19 Dec 202519 Dec 2025Announced-7.92%--
DB Orthodontics LtdAnnounced25 Nov 202525 Nov 2025Announced-6.69%--
Hegutechnik GmbH & Co. KGDeal completed31 Oct 202531 Oct 2025Deal completed-13.76%--
Nobil Bio Ricerche SrlDeal completed03 Oct 202503 Oct 2025Deal completed-0.74%--
Data delayed at least 15 minutes, as of Feb 06 2026 17:00 GMT.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.